Literature DB >> 7551190

Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS).

R R Ribchester1, J W Tsao, J A Barry, N Asgari-Jirhandeh, V H Perry, M C Brown.   

Abstract

The present study was undertaken to examine the fate of neuromuscular junctions in C57BL/WldS mice (formerly known as OLA mice) after nerve injury. When a peripheral nerve is injured, the distal axons normally degenerate within 1-3 days. For motor axons, an early event is deterioration of motor nerve terminals at neuromuscular junctions. Previously, the vulnerability of motor terminals has been attributed either to a 'signal' originating at the site of nerve injury and transported rapidly to the terminals or to their continual requirement for essential maintenance factors synthesized in the motor neuron cell body and supplied to the terminals by fast axonal transport. Mice of the WldS strain have normal axoplasmic transport but show an abnormally slow rate of axon and myelin degeneration. Structure and function are retained in the axons of distal nerve stumps for several days or even weeks after nerve injury in these mice. The results of the present study show that WldS neuromuscular junctions are also preserved and continue to release neurotransmitter and recycle synaptic vesicle membrane for at least 3 days and in some cases up to 2 weeks after nerve injury. Varying the site of the nerve lesion delayed degeneration by approximately 1-2 days per centimetre of distal nerve remaining. These findings suggest that the mechanisms of nerve terminal degeneration after injury are more complex than can be accounted for simply by the failure of motor neuron cell bodies to supply their terminals with essential maintenance factors. Rather, the data support the view that nerve section normally activates cellular components or processes already present, but latent, in motor nerve endings, and that in WldS mice either the trigger or the cellular response is abnormal.

Entities:  

Mesh:

Year:  1995        PMID: 7551190     DOI: 10.1111/j.1460-9568.1995.tb01159.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  21 in total

Review 1.  Wallerian degeneration, wld(s), and nmnat.

Authors:  Michael P Coleman; Marc R Freeman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 2.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 3.  Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse.

Authors:  T H Gillingwater; R R Ribchester
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

4.  Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice.

Authors:  Thomas H Gillingwater; Derek Thomson; Till G A Mack; Ellen M Soffin; Richard J Mattison; Michael P Coleman; Richard R Ribchester
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

Review 5.  Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme.

Authors:  Rong Grace Zhai; Menico Rizzi; Silvia Garavaglia
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

6.  Rapid loss of motor nerve terminals following hypoxia-reperfusion injury occurs via mechanisms distinct from classic Wallerian degeneration.

Authors:  Becki Baxter; Thomas H Gillingwater; Simon H Parson
Journal:  J Anat       Date:  2008-06       Impact factor: 2.610

7.  Ultrastructural correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and transgenic mice expressing the Wld gene.

Authors:  Thomas H Gillingwater; Cali A Ingham; Michael P Coleman; Richard R Ribchester
Journal:  J Anat       Date:  2003-09       Impact factor: 2.610

8.  Wld(S) reduces paraquat-induced cytotoxicity via SIRT1 in non-neuronal cells by attenuating the depletion of NAD.

Authors:  Qiujing Yu; Ting Wang; Xuexia Zhou; Jingxia Wu; Xingmiao Chen; Yang Liu; Dongmei Wu; Qiwei Zhai
Journal:  PLoS One       Date:  2011-07-05       Impact factor: 3.240

9.  NAD synthase NMNAT acts as a chaperone to protect against neurodegeneration.

Authors:  R Grace Zhai; Fan Zhang; P Robin Hiesinger; Yu Cao; Claire M Haueter; Hugo J Bellen
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

10.  Mutations in a P-type ATPase gene cause axonal degeneration.

Authors:  Xianjun Zhu; Richard T Libby; Wilhelmine N de Vries; Richard S Smith; Dana L Wright; Roderick T Bronson; Kevin L Seburn; Simon W M John
Journal:  PLoS Genet       Date:  2012-08-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.